Add BrightSurf on Google Email

Massachusetts General Hospital


Nanodiamond-enhanced MRI offers greater range of diagnostic and therapeutic applications

Researchers have developed a means of non-invasively tracking nanodiamonds with magnetic resonance imaging (MRI), opening up new applications in disease diagnosis and therapy. The technique uses the Overhauser effect to boost the weak magnetic resonance signal of diamond, allowing for high-contrast imaging over indefinite periods.

SourceMassachusetts General Hospital·JournalNature Communications·DateApr 26, 2017

Mass. General researchers provide evidence linking 'leaky gut' to chronic inflammation

Scientists at Massachusetts General Hospital have established a direct link between increased intestinal permeability and chronic inflammatory diseases. The study provides evidence that zonulin-dependent modulation of small-intestinal permeability enhances antigen trafficking, leading to the development of an inflammatory disease.

SourceMassachusetts General Hospital·JournalAnnals of the New York Academy of Sciences·DateApr 20, 2017

Finding positive in the negative

A phase 2 clinical trial of sacituzumab govitecan, an antibody-drug conjugate targeting Trop-2, achieved a response in 21 participants with advanced triple-negative breast cancer. The responses were early and durable, lasting up to 20 months, with improved overall survival.

SourceMassachusetts General Hospital·JournalJournal of Clinical Oncology·DateMar 14, 2017

'Red hair' gene variant may underlie association between melanoma and Parkinson's disease

A gene variant that produces red hair and fair skin in humans and mice has been found to contribute to the association between melanoma and Parkinson's disease. The study shows that mice carrying this variant have reduced dopamine production and increased sensitivity to toxins, making them more susceptible to neurodegeneration.

SourceMassachusetts General Hospital·JournalAnnals of Neurology·DateMar 2, 2017

Adding antiandrogen to radiation therapy improves survival in recurrent prostate cancer

A study by the NRG Oncology Radiation Therapy Oncology Group found that adding antiandrogen therapy to radiation therapy can reduce the incidence of metastasis, death from prostate cancer, and overall deaths in patients with recurrent prostate cancer. The study showed a significant improvement in survival rates for patients treated wit...

SourceMassachusetts General Hospital·JournalNew England Journal of Medicine·DateFeb 1, 2017

Changes in blood-brain barrier, intestinal permeability found in individuals with autism

Researchers found an altered blood-brain barrier and increased intestinal permeability in individuals with autism, supporting the hypothesis that impaired barriers contribute to ASD. The study also revealed reduced expression of barrier-forming cellular components and higher expression of molecules increasing intestinal permeability in...

SourceMassachusetts General Hospital·JournalMolecular Autism·DateJan 18, 2017

Many insured under the Affordable Care Act miss opportunities for financial assistance

A Massachusetts General Hospital study found that almost one-third of Californians enrolling in individual insurance plans under the Affordable Care Act (ACA) potentially missed opportunities to receive financial assistance. Enrollees who received certified enrollment counselor assistance were less likely to choose ineligible plans.

SourceMassachusetts General Hospital·JournalHealth Affairs·DateJan 11, 2017

Topical treatment activates immune system to clear precancerous skin lesions

Researchers at Massachusetts General Hospital discovered a combination of calcipotriol and fluorouracil can rapidly clear actinic keratosis lesions by activating the immune system, achieving an 88% reduction in facial lesions. The treatment's effectiveness was compared to standard treatments, which elicit unpleasant side effects.

SourceMassachusetts General Hospital·JournalJournal of Clinical Investigation·DateDec 19, 2016